IRadimed Corporation (IRMD)
57.49
0.98 (1.73%)
At close: Jan 14, 2025, 3:59 PM
57.52
0.05%
After-hours Jan 14, 2025, 04:06 PM EST
undefined% (undefined)
| Bid | 51.4 |
| Market Cap | 728.59M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 1.46 |
| PE Ratio (ttm) | 39.38 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 92.03 |
| Volume | 22,803 |
| Avg. Volume (20D) | 40,045 |
| Open | 56.91 |
| Previous Close | 56.51 |
| Day's Range | 56.09 - 57.98 |
| 52-Week Range | 40.18 - 58.41 |
| Beta | undefined |
About IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote dis...
Industry Medical - Devices
Sector Healthcare
IPO Date Jul 16, 2014
Employees 148
Stock Exchange NASDAQ
Ticker Symbol IRMD
Website https://www.iradimed.com
Analyst Forecast
According to 1 analyst ratings, the average rating for IRMD stock is "Buy." The 12-month stock price forecast is $60, which is an increase of 4.37% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
IRadimed Corporation is scheduled to release its earnings on Feb 6, 2025,
before market opens.
Analysts project revenue of $19.20M, reflecting a 10.02% YoY growth and earnings per share of 0.44, making a 12.82% increase YoY.
Analysts project revenue of $19.20M, reflecting a 10.02% YoY growth and earnings per share of 0.44, making a 12.82% increase YoY.
